Literature DB >> 15956432

Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Juan P Horcajada1, Sara Soto, Abby Gajewski, Alex Smithson, M Teresa Jiménez de Anta, Josep Mensa, Jordi Vila, James R Johnson.   

Abstract

The prevalence of 31 virulence factors was analyzed among nalidixic acid-susceptible and -resistant Escherichia coli strains from phylogenetic group B2. Hemolysin, cytotoxic necrotizing factor 1, and S and F1C fimbriae genes were less prevalent among nalidixic acid-resistant E. coli strains. Quinolone resistance may be associated with a decrease in the presence of some virulence factors.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15956432      PMCID： PMC1151912          DOI： 10.1128/JCM.43.6.2962-2964.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC.

Authors:  T A Russo; J R Johnson
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

2.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

Review 3.  Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution.

Authors:  J Hacker; G Blum-Oehler; I Mühldorfer; H Tschäpe
Journal:  Mol Microbiol       Date:  1997-03       Impact factor: 3.501

4.  Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Authors:  J Garau; M Xercavins; M Rodríguez-Carballeira; J R Gómez-Vera; I Coll; D Vidal; T Llovet; A Ruíz-Bremón
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

5.  Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections.

Authors:  M Velasco; J P Horcajada; J Mensa; A Moreno-Martinez; J Vila; J A Martinez; J Ruiz; M Barranco; G Roig; E Soriano
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

6.  Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.

Authors:  L Martínez-Martínez; F Fernández; E J Perea
Journal:  J Antimicrob Chemother       Date:  1999-02       Impact factor: 5.790

7.  Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'Bryan; Joel N Maslow
Journal:  J Infect Dis       Date:  2002-04-17       Impact factor: 5.226

8.  Differences in virulence factors among clinical isolates of Escherichia coli causing cystitis and pyelonephritis in women and prostatitis in men.

Authors:  Joaquim Ruiz; Karine Simon; Juan P Horcajada; Maria Velasco; Margarita Barranco; Gloria Roig; Antonio Moreno-Martínez; Jose A Martínez; Teresa Jiménez de Anta; Josep Mensa; Jordi Vila
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

9.  Are quinolone-resistant uropathogenic Escherichia coli less virulent?

Authors:  Jordi Vila; Karine Simon; Joaquin Ruiz; Juan P Horcajada; Maria Velasco; Margarita Barranco; Antonio Moreno; Josep Mensa
Journal:  J Infect Dis       Date:  2002-09-13       Impact factor: 5.226

10.  Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.

Authors:  James R Johnson; Cindy van der Schee; Michael A Kuskowski; Wil Goessens; Alex van Belkum
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226
View more
  31 in total

1.  Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively.

Authors:  S M Soto; M T Jimenez de Anta; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  LeuX tRNA-dependent and -independent mechanisms of Escherichia coli pathogenesis in acute cystitis.

Authors:  Thomas J Hannan; Indira U Mysorekar; Swaine L Chen; Jennifer N Walker; Jennifer M Jones; Jerome S Pinkner; Scott J Hultgren; Patrick C Seed
Journal:  Mol Microbiol       Date:  2007-11-25       Impact factor: 3.501

3.  Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.

Authors:  Petra Lüthje; Annelie Brauner
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

4.  Escherichia coli sequence type 131 as a prominent cause of antibiotic resistance among urinary Escherichia coli isolates from reproductive-age women.

Authors:  Timothy Kudinha; James R Johnson; Scott D Andrew; Fanrong Kong; Peter Anderson; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2013-07-24       Impact factor: 5.948

5.  Characterization of multidrug-resistant Gram-negative bacilli isolated from hospitals effluents: first report of a blaOXA-48-like in Klebsiella oxytoca, Algeria.

Authors:  Khadidja Yousfi; Abdelaziz Touati; Brigitte Lefebvre; Philippe Garneau; Soumia Brahmi; Alima Gharout-Sait; Josée Harel; Sadjia Bekal
Journal:  Braz J Microbiol       Date:  2018-12-19       Impact factor: 2.476

6.  Involvement of virulence properties and antibiotic resistance in Escherichia coli strains causing pyelonephritis in children.

Authors:  Ján Koreň; Katarína Čurová; Marta Kmeťová; Leonard Siegfried; Viktor Jankó; László Kovács; Helena Hupková; Ján Luha
Journal:  Folia Microbiol (Praha)       Date:  2012-06-21       Impact factor: 2.099

7.  Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates.

Authors:  Jesús Oteo; Juan José González-López; Adriana Ortega; J Natalia Quintero-Zárate; Germán Bou; Emilia Cercenado; María Carmen Conejo; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Rosa M Bartolomé; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

8.  Virulence characteristics and phylogenetic background of ciprofloxacin resistant Escherichia coli in the urine samples from Korean women with acute uncomplicated cystitis.

Authors:  Chul Sung Kim; Min Eui Kim; Yong-Hyun Cho; In Rae Cho; Gilho Lee
Journal:  J Korean Med Sci       Date:  2010-03-19       Impact factor: 2.153

9.  Virulence potential of Escherichia coli isolates from skin and soft tissue infections.

Authors:  Ziva Petkovsek; Kristina Elersic; Marija Gubina; Darja Zgur-Bertok; Marjanca Starcic Erjavec
Journal:  J Clin Microbiol       Date:  2009-04-08       Impact factor: 5.948

10.  (CGG)4-based PCR as a novel tool for discrimination of uropathogenic Escherichia coli strains: comparison with enterobacterial repetitive intergenic consensus-PCR.

Authors:  Wioletta Adamus-Bialek; Arkadiusz Wojtasik; Marta Majchrzak; Marek Sosnowski; Pawel Parniewski
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.